These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10097166)

  • 1. Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo.
    Yamada M; Oligino T; Mata M; Goss JR; Glorioso JC; Fink DJ
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):4078-83. PubMed ID: 10097166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration.
    Natsume A; Mata M; Goss J; Huang S; Wolfe D; Oligino T; Glorioso J; Fink DJ
    Exp Neurol; 2001 Jun; 169(2):231-8. PubMed ID: 11358438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in the cellular distribution of bcl-2, bcl-x and bax in the adult rat substantia nigra following striatal 6-hydroxydopamine lesions.
    Kramer BC; Mytilineou C
    J Neurocytol; 2004 Mar; 33(2):213-23. PubMed ID: 15322379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
    Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-Hydroxydopamine increases the level of TNFalpha and bax mRNA in the striatum and induces apoptosis of dopaminergic neurons in hemiparkinsonian rats.
    Mladenović A; Perović M; Raicević N; Kanazir S; Rakić L; Ruzdijić S
    Brain Res; 2004 Jan; 996(2):237-45. PubMed ID: 14697501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats.
    Mandel RJ; Spratt SK; Snyder RO; Leff SE
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):14083-8. PubMed ID: 9391156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor.
    Ding YM; Jaumotte JD; Signore AP; Zigmond MJ
    J Neurochem; 2004 May; 89(3):776-87. PubMed ID: 15086533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.
    Sauer H; Oertel WH
    Neuroscience; 1994 Mar; 59(2):401-15. PubMed ID: 7516500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson's disease.
    Yin LH; Shen H; Diaz-Ruiz O; Bäckman CM; Bae E; Yu SJ; Wang Y
    BMC Neurosci; 2012 Oct; 13():120. PubMed ID: 23040108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus vector-mediated expression of Bcl-2 protects spinal motor neurons from degeneration following root avulsion.
    Yamada M; Natsume A; Mata M; Oligino T; Goss J; Glorioso J; Fink DJ
    Exp Neurol; 2001 Apr; 168(2):225-30. PubMed ID: 11259110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. A possible mechanism for restoration of the nigrostriatal circuit mediated by glial cell line-derived neurotrophic factor.
    Bowenkamp KE; David D; Lapchak PL; Henry MA; Granholm AC; Hoffer BJ; Mahalik TJ
    Exp Brain Res; 1996 Sep; 111(1):1-7. PubMed ID: 8891630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C; Kirik D; Björklund A
    Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
    Choi-Lundberg DL; Lin Q; Schallert T; Crippens D; Davidson BL; Chang YN; Chiang YL; Qian J; Bardwaj L; Bohn MC
    Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies.
    Xu L; Sheng J; Tang Z; Wu X; Yu Y; Guo H; Shen Y; Zhou C; Paraoan L; Zhou J
    Neurobiol Dis; 2005 Feb; 18(1):152-65. PubMed ID: 15649706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatum.
    Ichitani Y; Okamura H; Matsumoto Y; Nagatsu I; Ibata Y
    Brain Res; 1991 May; 549(2):350-3. PubMed ID: 1679369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
    Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
    J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle.
    Rosenblad C; Kirik D; Devaux B; Moffat B; Phillips HS; Björklund A
    Eur J Neurosci; 1999 May; 11(5):1554-66. PubMed ID: 10215908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture.
    Chan WS; Durairajan SS; Lu JH; Wang Y; Xie LX; Kum WF; Koo I; Yung KK; Li M
    Neurochem Int; 2009 Nov; 55(6):414-22. PubMed ID: 19409437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.
    Pang Y; Lin S; Wright C; Shen J; Carter K; Bhatt A; Fan LW
    Neuroscience; 2016 Mar; 318():157-65. PubMed ID: 26777890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.